The latest research from Fore Pharma, Europe Hemophilia Market and Competitive Landscape – 2020, provides comprehensive insights into Hemophilia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Hemophilia market size and drug sales. It also provides insights into Hemophilia epidemiology and late stage pipeline.
This research covers the following – Hemophilia treatment options, Hemophilia late stage clinical trials pipeline, Hemophilia prevalence by countries, Hemophilia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Hemophilia pipeline: Find out drugs in clinical trials for Hemophilia by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Hemophilia epidemiology: Find out number of patients diagnosed (prevalence) with Hemophilia by countries
– Hemophilia drugs: Identify key drugs marketed and prescribed for Hemophilia by countries, including trade name, molecule name, and company
– Hemophilia drugs sales: Find out the sales value for Hemophilia drugs by countries
– Hemophilia market valuations: Find out the market size for Hemophilia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Hemophilia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Hemophilia drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Hemophilia market
– Develop in-depth knowledge of competition and markets
– Analyze Hemophilia drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Hemophilia market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Hemophilia Treatment Options
2. Hemophilia Pipeline Insights
2.1. Hemophilia Phase 3 Clinical Trials
2.2. Hemophilia Phase 2 Clinical Trials
2.3. Hemophilia Phase 1 Clinical Trials
3. Hemophilia Epidemiology Analysis by Countries
4. Germany Hemophilia Market Insights
4.1. Marketed Drugs for Hemophilia in Germany
4.2. Germany Hemophilia Market Size & Forecast
4.3. Germany Hemophilia Drugs Sales Forecast
4.4. Germany Hemophilia Market Share Analysis
5. France Hemophilia Market Insights
5.1. Marketed Drugs for Hemophilia in France
5.2. France Hemophilia Market Size & Forecast
5.3. France Hemophilia Product Sales Forecast
5.4. France Hemophilia Market Share Analysis
6. Italy Hemophilia Market Insights
6.1. Marketed Drugs for Hemophilia in Italy
6.2. Italy Hemophilia Market Size & Forecast
6.3. Italy Hemophilia Product Sales Forecast
6.4. Italy Hemophilia Market Share Analysis
7. Spain Hemophilia Market Insights
7.1. Marketed Drugs for Hemophilia in Spain
7.2. Spain Hemophilia Market Size & Forecast
7.3. Spain Hemophilia Product Sales Forecast
7.4. Spain Hemophilia Market Share Analysis
8. UK Hemophilia Market Insights
8.1. Marketed Drugs for Hemophilia in UK
8.2. UK Hemophilia Market Size & Forecast
8.3. UK Hemophilia Product Sales Forecast
8.4. UK Hemophilia Market Share Analysis
9. Europe Hemophilia Market Insights
9.1. Europe Hemophilia Market Size & Forecast
9.2. Europe Hemophilia Product Sales Forecast
9.3. Europe Hemophilia Market Share Analysis
10. Research Methodology
List of Tables
1: Hemophilia Phase 3 Clinical Trials, Global, 2020
2: Hemophilia Phase 2 Clinical Trials, Global, 2020
3: Hemophilia Phase 1 Clinical Trials, Global, 2020
4: Hemophilia Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Hemophilia in Germany, 2019
6: Germany Hemophilia Market Size & Forecast ($mn), 2016 – 2025
7: Germany Hemophilia Product Sales ($mn), 2016 – 2025
8: Germany Hemophilia Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Hemophilia in France, 2019
10: France Hemophilia Market Size & Forecast ($mn), 2016 – 2025
11: France Hemophilia Product Sales ($mn), 2016 – 2025
12: France Hemophilia Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Hemophilia in Italy, 2019
14: Italy Hemophilia Market Size & Forecast ($mn), 2016 – 2025
15: Italy Hemophilia Product Sales ($mn), 2016 – 2025
16: Italy Hemophilia Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Hemophilia in Spain, 2019
18: Spain Hemophilia Market Size & Forecast ($mn), 2016 – 2025
19: Spain Hemophilia Product Sales ($mn), 2016 – 2025
20: Spain Hemophilia Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Hemophilia in UK, 2019
22: UK Hemophilia Market Size & Forecast ($mn), 2016 – 2025
23: UK Hemophilia Product Sales ($mn), 2016 – 2025
24: UK Hemophilia Market Events and Trends, 2016 – 2025
25: Europe Hemophilia Market Size & Forecast ($mn), 2016 – 2025
26: Europe Hemophilia Product Sales ($mn), 2016 – 2025
List of Figures
1: Hemophilia Pipeline by Phase (%), Global, 2020
2: Hemophilia Prevalence by Countries, 2016 – 2025
3: Germany Hemophilia Market Size ($mn), 2016 – 2025
4: Germany Hemophilia Product Sales ($mn), 2016 – 2025
5: Germany Hemophilia Market Share by Drugs (%), 2019
6: Germany Hemophilia Market – Future Market Share (%), 2025
7: France Hemophilia Market Size ($mn), 2016 – 2025
8: France Hemophilia Product Sales ($mn), 2016 – 2025
9: France Hemophilia Market Share by Drugs (%), 2019
10: France Hemophilia Market – Future Market Share (%), 2025
11: Italy Hemophilia Market Size ($mn), 2016 – 2025
12: Italy Hemophilia Product Sales ($mn), 2016 – 2025
13: Italy Hemophilia Market Share by Drugs (%), 2019
14: Italy Hemophilia Market – Future Market Share (%), 2025
15: Spain Hemophilia Market Size ($mn), 2016 – 2025
16: Spain Hemophilia Product Sales ($mn), 2016 – 2025
17: Spain Hemophilia Market Share by Drugs (%), 2019
18: Spain Hemophilia Market – Future Market Share (%), 2025
19: UK Hemophilia Market Size ($mn), 2016 – 2025
20: UK Hemophilia Product Sales ($mn), 2016 – 2025
21: UK Hemophilia Market Share by Drugs (%), 2019
22: UK Hemophilia Market – Future Market Share (%), 2025
23: Europe Hemophilia Market Size ($mn), 2016 – 2025
24: Europe Hemophilia Product Sales ($mn), 2016 – 2025
25: Europe Hemophilia Market Share by Drugs (%), 2019
26: Europe Hemophilia Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.